Robert N. Shapiro’s Teva Pharmaceuticals TEVA Stock Holding History

Robert N. Shapiro’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$824K	Buy	14,335 +1,200	+9%	+$66.9K	0.16%	139
2014 Q3	$705K	Hold	13,135	–	–	0.13%	150
2014 Q2	$689K	Sell	13,135 -145	-1%	-$7.41K	0.13%	150
2014 Q1	$702K	Sell	13,280 -744	-5%	-$34.4K	0.13%	153
2013 Q4	$562K	Sell	14,024 -2,671	-16%	-$105K	0.1%	169
2013 Q3	$631K	Sell	16,695 -13,140	-44%	-$513K	0.11%	158
2013 Q2	$1.17M	Buy	+29,835	New	+$1.16M	0.25%	116

Other funds holding TEVA

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Robert N. Shapiro's TEVA Position: Q4 2014 in Review

Robert N. Shapiro increased its Teva Pharmaceuticals (TEVA) stake by 9.1% in Q4 2014, buying an estimated $66.9K and bringing the position to 14,335 shares worth $824K. The position accounts for 0.16% of the portfolio, ranked #139.

Robert N. Shapiro first reported a position in TEVA in Q2 2013 and has held it in 7 quarters since. The position peaked at $1.17M in Q2 2013. 821 funds tracked by Wall St. Rank hold TEVA as of Q4 2014.

Robert N. Shapiro held 14,335 shares of Teva Pharmaceuticals worth $824K as of Q4 2014.
Robert N. Shapiro bought 1,200 Teva Pharmaceuticals shares in Q4 2014, an estimated $66.9K.
Teva Pharmaceuticals made up 0.16% of Robert N. Shapiro's portfolio in Q4 2014, its #139 holding.
Robert N. Shapiro first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 7 quarters since.
Robert N. Shapiro's Teva Pharmaceuticals position peaked at $1.17M in Q2 2013.
821 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2014.

Based on Robert N. Shapiro's 13F filing for Q4 2014, filed 19 Feb 2015.